Gem Aromatics IPO
GEMAROMA

₹14,950 / 46 shares

RHP/DRHP

Issue Date

19 Aug - 21 Aug'25

Price Range

₹309 - ₹325

Lot Size

46

IPO Size

₹317.93 Cr

Gem Aromatics IPO Listing Details

Listing On

26 Aug'25

Issue Price

₹325

Listed Price

₹ 325

Retail Gain/Listing Gain

--

Schedule of Gem Aromatics IPO

Start date

19/08/2025

End date

21/08/2025

Allotment of bids

22/08/2025

Refund Initiation

Listing on exchange

26/08/2025

(Last updated on 21 Aug 2025 04:45 PM)

(As On, August 21, 2025, 10:39 AM)

Gem Aromatics Limited is planning an Initial Public Offering (IPO) consisting of a fresh issue and an offer for sale. The fresh issue involves equity shares with a face value of ₹2, aggregating up to ₹175 crores, while the offer for sale includes up to 8,924,274 equity shares of ₹2 each. The total offer size will combine these components, with the exact aggregate value yet to be disclosed.

  • Prepay or repay, fully or partially, the outstanding loans taken by the company and its subsidiary, Krystal Ingredients Private Limited.

  • General corporate purposes.

The Indian chemical industry is diversified, with specialty chemicals leading in growth. India is poised to benefit from the global shift towards sustainability and changing market dynamics. The specialty chemicals sector is attracting investment as companies diversify away from China, adopting a China+1 strategy. The sector has experienced an average growth rate of 15% in the past five years. The industry outlook thus remains positive, with India emerging as a key player in the global market.

Gem Aromatics Limited is an Indian manufacturer of specialty ingredients, such as essential oils, aroma chemicals, and value-added derivatives. The company has a track record of over two decades and serves a variety of industries, including oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.

Gem Aromatics commenced operations in 1999 with a focus on mint and mint derivatives, expanding into clove and clove derivatives in 2009. The company's product portfolio includes 70 products across four categories: mint and mint derivatives, clove and clove derivatives, phenol, and other synthetic and natural ingredients.

Dependence on key customers: The company derives a significant portion of its revenue from a limited number of key customers, including its top customer, dōTERRA.

Litigation risk related to Budaun Factory: The company is involved in an on-going litigation in the Supreme Court of India with respect to the land on which their Budaun Facility is located. Any adverse outcome in such proceedings may have an adverse effect on their business, results of operations, financial condition and cash flows.

Reliance on third-party suppliers and logistics: The company relies on third-party suppliers for its raw materials and logistics providers for the delivery of its products, which exposes it to risks associated with supply chain disruptions, price fluctuations, and logistics challenges.

Loading chart...

Registrar: KFin Technologies Limited

Book Running Lead Manager: Motilal Oswal Investment Advisors Limited

Gem Aromatics Limited manufactures and sells specialty ingredients such as essential oils, aroma chemicals, and value-added derivatives. It offers a diversified product range from mother ingredients to value-added derivatives. The company sells its products both domestically and internationally. It focuses on selling natural, natural-like, and synthetic essential oils to industries like flavours, fragrances, FMCG, and pharmaceuticals.

Gem Aromatics has experienced a consistent increase in revenue from operations and EBITDA over the past three fiscal years. In Fiscal 2024, revenue from operations grew by 6.51% to ₹452.45 crores from ₹424.79 crores in Fiscal 2023. EBITDA also increased by 18.38% to ₹78.35 crores in Fiscal 2024 from ₹66.18 crores in Fiscal 2023.

1. Visit the Registrar's Website

To check the IPO allotment status for Gem Aromatics Limited IPO, visit the official website of KFin Technologies Limited, the registrar for this IPO. On their IPO allotment status page, enter your Permanent Account Number (PAN), application number, or Demat account ID. Then, click the ‘Submit’ button to view your allotment status. Ensure you have the necessary details ready for a quick and accurate check.

2. Check on the Bombay Stock Exchange Website

The Bombay Stock Exchange (BSE) also has an IPO allotment status page. Go to www.bseindia.com and find the 'Investors' tab. Under 'Investors', click on 'IPO'. This will take you to the IPO allotment status page.

On the BSE IPO page, follow these steps:

  • Select 'Equity' from the dropdown menu
  • Choose 'Gem Aromatics Limited' in the next dropdown
  • Enter your application number
  • Enter your PAN
  • Click 'Search' Your Gem Aromatics IPO allotment status will be displayed.

3. Verify on the National Stock Exchange Website

The National Stock Exchange (NSE) has an IPO Bid Verification module. Use this to check Gem Aromatics IPO allotment status.

Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'. On the NSE IPO Bid Verification page, enter:

  • Application number
  • PAN

Then click 'Submit'. Your Gem Aromatics IPO bid and allotment details will be displayed.

  • Step 1: Log in to your Kotak Neo Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  • Step 2: Specify IPO details - Enter the number of lots and the price you wish to apply for.
  • Step 3: Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
  • Step 4: Mandate Notification - Your UPI app will receive a mandate notification to block funds.
  • Step 5: Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.

The Gem Aromatics IPO opens for subscription from 19-08-2025 to 21-08-2025, with a total issue size of ₹317.93 Cr. The IPO price band is ₹309 to ₹325 per share with a lot size of 46. The company aims to list the shares on BSE & NSE on 26-08-2025.

The Gem Aromatics IPO will open for subscription on 19-08-2025 and will close on 21-08-2025 for investors.

The minimum lot size for the Gem Aromatics IPO is 46 equity shares, requiring a minimum investment of ₹14950 for retail investors applying in the IPO.

The price band of the Gem Aromatics IPO has been fixed at ₹309 to ₹325 per equity share.

You can apply for the Gem Aromatics IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.

Gem Aromatics IPO allotment will take place on 22-08-2025.

You can check the Gem Aromatics IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.

Gem Aromatics shares will list on the stock exchanges on 26-08-2025.

You can find detailed information about the Gem Aromatics IPO, including its business operations, financial performance, risk factors, and IPO objectives, in the Draft or Red Herring Prospectus (RHP).

Gem Aromatics Ltd IPO consists of a fresh issue involves equity shares of up to ₹175 crore, while the offer for sale includes up to 8,924,274 equity shares.

Yes, Gem Aromatics Ltd is expected to come up with its IPO soon.

Vipul Parekh is the chairman of Gem Aromatics.

The company hasn’t given any information on the lot size yet.

You may read more about Gem Aromatics and its IPO from the company’s draft red herring prospectus (DRHP) here

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Neo Research Team, nor is it a report published by the Kotak Neo Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.